Montag & Associates’s Albemarle ALB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-19
Closed -$1.55K 954
2025
Q3
$1.55K Buy
+19
New +$1.47K ﹤0.01% 953
2025
Q1
Sell
-12
Closed -$1.04K 996
2024
Q4
$1.04K Hold
12
﹤0.01% 949
2024
Q3
$1.31K Sell
12
-415
-97% -$36.8K ﹤0.01% 950
2024
Q2
$41K Hold
427
﹤0.01% 621
2024
Q1
$56.4K Hold
427
﹤0.01% 572
2023
Q4
$61.9K Hold
427
﹤0.01% 538
2023
Q3
$72.8K Sell
427
-67
-14% -$13.3K ﹤0.01% 489
2023
Q2
$110K Hold
494
0.01% 462
2023
Q1
$109K Hold
494
0.01% 457
2022
Q4
$107K Hold
494
0.01% 439
2022
Q3
$131K Hold
494
0.01% 409
2022
Q2
$103K Hold
494
0.01% 433
2022
Q1
$109K Buy
494
+12
+2% +$2.54K 0.01% 455
2021
Q4
$113K Buy
+482
New +$119K 0.01% 454

Other funds holding ALB

Montag & Associates's ALB Position: Q4 2025 in Review

Montag & Associates sold out of Albemarle (ALB) in Q4 2025, closing a stake of 19 shares — an estimated $1.55K sold.

Montag & Associates first reported a position in ALB in Q4 2021 and held it in 14 quarters. The position peaked at $131K in Q3 2022. 909 funds tracked by Wall St. Rank hold ALB as of Q4 2025.

  • Montag & Associates reported no remaining Albemarle position as of Q4 2025 after selling out during the quarter.
  • Montag & Associates sold 19 Albemarle shares in Q4 2025, an estimated $1.55K.
  • Montag & Associates first reported a position in Albemarle in Q4 2021 and held it in 14 quarters.
  • Montag & Associates's Albemarle position peaked at $131K in Q3 2022.
  • 909 funds tracked by Wall St. Rank held Albemarle as of Q4 2025.

Based on Montag & Associates's 13F filing for Q4 2025, filed 2 Feb 2026.